Results 101 to 110 of about 9,439 (180)
It summarizes the key findings: improves sleep quality (SMD0.97) and depressive symptoms(SMD0.61) in depression‐related insomia ABSTRACT Background This meta‐analysis evaluated the efficacy of high‐frequency repetitive transcranial magnetic stimulation (HF‐rTMS) targeting the left dorsolateral prefrontal cortex (DLPFC) in patients with comorbid ...
Wenqing Yang +5 more
wiley +1 more source
Neurotensin colocalizes with orexin in LHA neurons.
A, Immunostaining of neurotensin in a coronal section of mouse brain. Dense staining of neurotensin-like immunoreactivity is observed in the central nucleus of the amygdala (CeA), lateral hypothalamic area (LHA) and zona incerta (ZI).
Seiji Shioda (204796) +7 more
core +1 more source
This is a meta‐analysis of 39 studies comprising 14,094 cancer patients across 16 countries. The pooled global prevalence was 34.6% (95% CI: 27.2–44.1). Subgroup analyses revealed a higher prevalence in high‐income countries compared to low‐income countries. Meta‐regression showed that smaller sample size was associated with higher prevalence estimates.
Ting Du, Linyu Luo, Langli Gao, Juan Lv
wiley +1 more source
Advances in Multidimensional Molecular Mechanisms of Epilepsy and Precision Therapy Strategies
Epilepsy arises from a multidimensional network imbalance, integrating genetic, inflammatory, and metabolic disruptions. This complexity drives neuronal hyperexcitability and underpins therapeutic challenges. Our review highlights how emerging precision strategies, from targeted molecular therapies to neuromodulation, offer a transformative path toward
Yimin Han +7 more
wiley +1 more source
Objective Cerebrospinal fluid (CSF) orexin‐A has been suggested to be a biomarker of Alzheimer disease (AD). In both cognitively unimpaired healthy older adults and individuals with symptomatic AD, CSF orexin‐A is positively associated with CSF Aβ42, p ...
Ruijin Lu +13 more
doaj +1 more source
Abstract Background and Objectives Managing substance use disorders (SUDs) is limited by the lack of longitudinal clinical data during active use and recovery. Wearable devices may help address this gap by capturing physiological and behavioral data in real‐world settings.
Alexandra Sas +10 more
wiley +1 more source
The orexigenic system was discovered in 1998. It consists of two neuropeptides, Orexin A and Orexin B. Researchers have focused more on Orexin A, since its intracerebroventricular injection into the lateral ventricle of the rat's brain causes an increase
P. Papakonstantinou +6 more
doaj +1 more source
Opioid withdrawal syndrome‐associated cognitive impairment: A narrative review
Abstract Background and Objectives Opioid withdrawal syndrome (OWS) comprises a transient constellation of subjective symptoms and objective signs expressed by brain and other organs. Although cognitive impairment is well documented in opioid use and addiction, little is known about cognitive impairment that may specifically accompany OWS.
Faizan Khan +2 more
wiley +1 more source
Life‐long cardiorespiratory consequences of early life stress on estrogen actions in female rats
Abstract Early‐life adversity increases risk for disease with sex‐specific effects on brain development. While the association between early‐life stress and neuropsychiatric disorders is well established, its impact on respiratory health is poorly documented, particularly in females.
Richard Kinkead +3 more
wiley +1 more source
Orexin-1 receptor signalling in the prelimbic cortex and ventral tegmental area regulates cue-induced reinstatement of ethanol-seeking in IP ...
SYS Khoo (15829220) +5 more
core

